Fraunhofer Institute for Cell Therapy and Immunology IZI
Department of Cellular Immunotherapy
End-to-End CAR T Innovation: Discovery, Manufacturing & Clinical Strategy
The Department of Cellular Immunotherapy in Würzburg identifies therapeutically relevant targets on cancer cells and develops new CAR T cell products for cell-based immunotherapies. The team creates cost-effective, rapid manufacturing methods using non-viral gene transfer, from R&D to final product analysis.
Close collaboration with the University Hospital Würzburg provides access to a wide clinical trial network, enabling fast translation of innovative therapies and strong expertise in preclinical and clinical analysis of genetically modified immune cells.